Follow
YANBIN FU
YANBIN FU
Weill Cornell Medicine
Verified email at med.cornell.edu
Title
Cited by
Cited by
Year
Lactobacillus rhamnosus GG induces cGAS/STING-dependent type I interferon and improves response to immune checkpoint blockade
W Si, H Liang, J Bugno, Q Xu, X Ding, K Yang, Y Fu, RR Weichselbaum, ...
Gut 71 (3), 521-533, 2022
1682022
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity
Y Hou, HL Liang, X Yu, Z Liu, X Cao, E Rao, X Huang, L Wang, L Li, ...
Science translational medicine 13 (582), eabb0130, 2021
502021
Cross-neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike
S Changrob, Y Fu, JJ Guthmiller, PJ Halfmann, L Li, CT Stamper, ...
Mbio 12 (6), e02975-21, 2021
332021
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
S Changrob, PJ Halfmann, H Liu, JL Torres, JJC McGrath, G Ozorowski, ...
The Journal of Clinical Investigation 133 (8), 2023
92023
Identification of two nonrearranging IgSF genes in chicken reveals a novel family of putative remnants of an antigen receptor precursor
Y Fu, Z Yang, J Huang, X Cheng, X Wang, S Yang, L Ren, Z Lian, H Han, ...
The Journal of Immunology 202 (7), 1992-2004, 2019
82019
Cross-neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike. mBio 12: e0297521
S Changrob, Y Fu, JJ Guthmiller, PJ Halfmann, L Li, CT Stamper, ...
52021
Genetic removal of the CH1 exon enables the production of heavy chain-only IgG in mice
T Zhang, X Cheng, D Yu, F Lin, N Hou, X Cheng, S Hao, J Wei, L Ma, Y Fu, ...
Frontiers in Immunology 9, 2202, 2018
52018
Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens
L Li, S Changrob, Y Fu, O Stovicek, JJ Guthmiller, JJC McGrath, ...
Briefings in Bioinformatics 23 (2), bbac028, 2022
42022
A hybrid single cell demultiplexing strategy that increases both cell recovery rate and calling accuracy.
L Li, J Sun, Y Fu, S Changrob, JJC McGrath, PC Wilson
Biorxiv: the Preprint Server for Biology, 2023
32023
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants
S Changrob, PJ Halfmann, H Liu, JL Torres, JJC McGrath, G Ozorowski, ...
bioRxiv, 2022.10. 31.514592, 2022
22022
Corrigendum: genetic removal of the CH1 exon enables the production of heavy chain-only IgG in mice
T Zhang, X Cheng, D Yu, F Lin, N Hou, X Cheng, S Hao, J Wei, L Ma, Y Fu, ...
Frontiers in Immunology 10, 398, 2019
22019
A hybrid demultiplexing strategy that improves performance and robustness of cell hashing
L Li, J Sun, Y Fu, S Changrob, JJC McGrath, PC Wilson
bioRxiv, 2023
12023
Librator, a platform for optimized sequence editing, design, and expression of influenza virus proteins
L Li, O Stovicek, JJ Guthmiller, S Changrob, Y Fu, HL Dugan, CT Stamper, ...
bioRxiv, 2021.04. 29.441999, 2021
12021
A hybrid demultiplexing strategy that improves performance and robustness of cell hashing
L Li, J Sun, Y Fu, S Changrob, JJC McGrath, PC Wilson
Briefings in Bioinformatics 25 (4), bbae254, 2024
2024
Mutability and hypermutation antagonize immunoglobulin codon optimality
JJC McGrath, J Park, CA Troxell, JC Chervin, L Li, JR Kent, S Changrob, ...
bioRxiv, 2024.03. 13.584690, 2024
2024
TUMOR TARGETED TYPE I INTERFERON ENGAGES DENDRITIC CELLS TO ENHANCE THE ANTI-TUMOR RESPONSE TO RADIOTHERAPY.
J Bugno, L Wang, Y Fu, R Weichselbaum, H Liang
CLINICAL PHARMACOLOGY & THERAPEUTICS 111, S11-S11, 2022
2022
Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike (preprint)
P Wilson, S Changrob, Y Fu, J Guthmiller, P Halfmann, L Li, C Stamper, ...
2021
The system can't perform the operation now. Try again later.
Articles 1–17